Point of care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Global Forecast to 2030

Point of care Diagnostics Market Size & Forecast

Point of care Diagnostics Market is expected to reach $43.1 billion by 2030, at a CAGR of 5.1% from 2023–2030. The growth of this market is driven by the increasing prevalence of chronic diseases, innovations in PoC testing, development of CLIA-waived PoC testing, and lack of Skilled technicians for performing lab tests. In addition, emerging markets and healthcare professionals’ increasing preference for PoC tests over lab tests are expected to offer significant market growth opportunities. However, pricing pressure due to fluctuations in reimbursements restrains the growth of this market.

Technological Trends in the Point-of-care Diagnostics Market

Technological trends such as lateral flow assays containing DNA nanostructures, rapid real-time polymerization chain reaction (PCR) tests, smartphone-based detection platforms, and nanoelectronic biosensors in point-of-care diagnostics lead to growth in demand for PoC diagnostics products.

Traditional antibodies in lateral flow assays can be replaced with DNA nanostructures capable of binding with a target antigen with high binding affinity and specificity. For example, Atom Bioworks Inc. (U.S.) has developed the DNA Star PoC Diagnostics Platform, a lateral flow assay kit that contains nanoengineered DNA nanostructures instead of traditional antibodies. In 2021, the company was awarded the Rapid Testing Innovation Award at the Advanced Lateral Flow Conference organized by DCN Diagnostics (U.S.) and DIALUNOX GmbH (Germany).

Smartphone-based platforms find applications in tele-imaging, food technology, and education. Smartphone-based detection is versatile and has a wide range of medical applications. Point-of-care diagnostics play a key role in screening patients at any healthcare unit. With high diagnosis costs and the limited availability of benchtop readers in remote/resourceless areas, the demand for smartphone-based point-of-care diagnostics is rising continuously.

Click here to: Get a Free Sample Copy of this report

Emerging Markets Create an Opportunity for the Market Growth

Emerging economies are fueling the demand for healthcare services and treatments due to rapid urbanization, improving healthcare infrastructures, increasing healthcare expenditures, growing healthcare insurance coverage, rising disposable incomes, and the growing prevalence of non-communicable and infectious diseases.

According to World Bank data, the total population in emerging countries is projected to reach 3.4 billion by 2050. Similarly, diabetes cases in emerging countries are rising. According to the IDF Diabetes Atlas 2021, diabetes cases in South Africa, India, Malaysia, Brazil, China, and Thailand increased from 171.6 million in 2011 to 245.5 million in 2021, indicating the high potential for the adoption of point-of-care diagnostic kits for blood glucose screening.

Moreover, growing urbanization and rising GDP per capita drive the demand for healthcare services and treatments in emerging economies such as South Africa, India, Brazil, China, Bangladesh, and Thailand. Growing urbanization indicates higher wages, a better quality of life, and improved access to healthcare services. Therefore, growing urbanization in emerging economies is expected to drive the development of healthcare systems, increasing people’s access to healthcare services and leading to the proliferation of hospitals, clinics, and diagnostic laboratories in these countries.

Key Findings of the Point-of-care Diagnostics Market Study:

Based on Offering, the Consumables Segment is Estimated to Dominate the Point-of-care Diagnostics Market in 2023

Based on offering, the global point-of-care diagnostics market is segmented into consumables, instruments, and software and services. In 2023, the consumables segment is expected to account for the largest share of the global point-of-care diagnostics market. The large market share of this segment is attributed to the benefits offered by point-of-care diagnostics kits, such as ease of use, portability, and accuracy.

PoC diagnostic kits are pre-packaged sets of materials and reagents used for performing tests. These diagnostic kits are user-friendly, with clear instructions for use and require minimal training, making them ideal for use in settings with limited access to trained laboratory personnel, such as rural or remote areas.

The Molecular Diagnostics Platform Segment is Expected to Register the Highest CAGR During the Forecast Period

Based on platform, the global point-of-care diagnostics market is segmented into lateral flow assays (LFA), molecular diagnostics, and other platforms. The molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by the high sensitivity and accuracy of these tests, the growing need for advanced diagnostic techniques, and the widening applications of molecular detection tests in various fields.

Based on Application, in 2023, the Blood Glucose Monitoring Segment is Estimated to Account for the Largest Share of the Market

Based on application, the global point-of-care diagnostics market is segmented into infectious disease testing, blood glucose monitoring, cardiac marker/cardiac metabolism testing, COVID-19 testing, coagulation testing, pregnancy and fertility testing, fecal occult testing, hematology, tumor/cancer markers testing, drugs of abuse testing, urinalysis, cholesterol/lipid profile testing, other POC testing.

In 2023, the blood glucose monitoring segment is expected to account for the largest share of the global POC diagnostics market. The increased prevalence of diabetes and the need for glucose monitoring devices increased the demand for blood glucose monitoring PoC diagnostics devices.

The Blood Sample Type Segment is Expected to Register the Highest CAGR During the Forecast Period

Based on sample type, the global point-of-care diagnostics market is segmented into blood sample, urine sample, saliva sample, nasopharyngeal swab, and other sample types. The blood sample type segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by the availability of a wide range of tests that can be conducted using blood samples, the growing prevalence of chronic diseases, and an increasing awareness among consumers about the importance of self-monitoring.

The Home Care/Self-Testing Segment is Expected to Register the Highest CAGR during the Forecast Period

Based on end user, the global point-of-care diagnostics market is segmented into home care/self-testing, hospitals, physician offices & ambulatory care settings, diagnostics laboratories, and other end users. The fast growth of the home care/self-testing segment is primarily attributed to the increasing prevalence of chronic diseases requiring long-term care and frequent monitoring, increasing home healthcare spending, growing awareness about home care, and the increasing availability of user-friendly and advanced POC diagnostic products. For instance, in the U.S., home healthcare spending increased from USD 88,800 million in 2015 to USD 1,17,100 million in 2020.

Asia-Pacific: Fastest Growing Regional Market

Asia-Pacific is expected to register the highest CAGR during the forecast period. Asia-Pacific is becoming an attractive market for healthcare product manufacturers due to the continuous improvement in the healthcare infrastructure, the rising number of hospitals, and growing government investment in this sector. Accelerated economic growth in many countries of the Asia-Pacific region has relatively increased the focus of various governments on the healthcare sector in terms of increased investments to enhance the accessibility to healthcare facilities and build better healthcare infrastructure.

Point of care Diagnostics Companies

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years. The key players operating in the global point-of-care diagnostics market are Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Chembio Diagnostics, Inc. (U.S.), EKF Diagnostics Holdings plc (U.K.), Trinity Biotech plc (Ireland), Werfen (Spain), Nova Biomedical (U.S.), Sekisui Diagnostics, LLC. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and bioMérieux S.A. (France).

Scope of Point of care Diagnostics Market Report:

Point-of-care Diagnostics Market Assessment, by Offering

• Consumables
• Instruments
• Software and Services

Point-of-care Diagnostics Market Assessment, by Platform

• Lateral Flow Assays
• Molecular Diagnostics
• Other Platforms
  (Note: Other platforms majorly include coagulation tests, dipsticks, cholesterol and glucose monitoring systems, and other point-of-care diagnostic platforms)

Point-of-care Diagnostics Market Assessment, by Application

• Blood Glucose Monitoring
• Infectious Disease Testing
  • Parasitic Infection Testing
  • Blood-borne Infection Testing
    • Hepatitis
    • HIV
    • Other Blood-borne Infections
  • Respiratory Infections Testing
    • Influenza
    • Pneumonia
    • Other Respiratory Infections Testing
  • Healthcare-associated Infection (HAI) Testing
  • Gastrointestinal (GI) Infection Testing
    • Salmonellosis
    • E. Coli Infections
    • Other GI Infections
  • Other Infectious Disease Testing
• COVID-19 Testing
• Tumor/Cancer Markers Testing
• Pregnancy And Fertility Testing
  • Pregnancy Testing
  • Fertility Testing
• Cardiac Marker/Cardiac Metabolism Testing
• Cholesterol/Lipid Profile Testing
• Coagulation Testing
  • Prothrombin Time (PT/INR) Testing
  • Activated Clotting Time (ACT/APTT) Testing
  • Other Coagulation Testing
• Hematology
• Drugs Of Abuse Testing
• Urinalysis
• Other PoC Testing
  (Other respiratory infections testing include strep infections and respiratory syncytial virus (RSV). Other GI infections include cholera, Helicobacter pylori (H. pylori), and campylobacteriosis. Other blood-borne diseases include syphilis and brucellosis. Other infectious disease testing includes meningitis, hand, foot, and mouth disease (HFMD), and mononucleosis. Other coagulation testing segment includes fibrinogen level and platelet count. Other PoC testing includes tropical diseases and sexually transmitted diseases)

Point-of-care Diagnostics Market Assessment, by Sample Type

• Blood Sample
• Nasopharyngeal Swab
• Urine Sample
• Saliva Sample
• Other Sample Types
  (Other sample types include stool, cervical swab, buccal swab, hair, vaginal swab, and semen)

Point-of-care Diagnostics Market Assessment, by End User

• Hospitals
• Home care/self-testing
• Physician Offices & Ambulatory Care Settings
• Diagnostics Laboratories
• Other End Users
  (Other end users include nursing homes, long-term care centers, pharmacies, urgent care facilities, schools, airports, hotels, and workplaces)

Point-of-care Diagnostics Market Assessment, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa

Key questions answered in the report: